12 Δεκ 2025
Partners met to review progress and next steps
The iPROLEPSIS consortium held its 7th Plenary Meeting on 9–10 December 2025 in Lisbon, Portugal, organised by the Sociedade Portuguesa de Reumatologia (SPR) and hosted at NOVA Medical School. Partners joined on site and remotely for two days of focused discussions on project progress, upcoming study deployments, and priorities for the next phase of the project.
Reviewing progress and open scientific issues
The first day of the meeting focused on reviewing overall project progress and aligning partners on key scientific and technical developments. Updates were shared across multiple work packages, covering advances in digital phenotyping, data harmonisation, and system development.
Dedicated sessions addressed open issues related to digital phenotyping methodologies and data analysis, while partners also discussed progress on data harmonisation activities supporting the project’s clinical studies. An External Advisory Board session provided valuable scientific and strategic feedback on project progress, ongoing work, and next steps.
The day included a tour of NOVA Medical School facilities, offering participants insight into the host institution’s research environment.
Clinical studies, ecosystem updates, and coordination
The second day focused on updates from the project’s clinical studies, including IDBV, PPIDC, MOJMI, and PDPID, with detailed discussions on timelines, technical readiness, and preparations for upcoming deployments.
Partners also reviewed progress on the iPROLEPSIS ecosystem, including mobile applications, data management systems, and orchestration components. Coordination, ethics, dissemination, exploitation, and regulatory planning activities were discussed, helping to define clear priorities for the months ahead.
Moving forward
The meeting concluded with a summary of agreed actions and priorities for the next project phase. Partners will now focus on advancing preparations for the deployment of clinical studies, addressing open technical and methodological issues, strengthening coordination across the ecosystem, and continuing dissemination, exploitation, and regulatory planning activities.
